A video shared by Whole Mars Catalog on November 2, 2026, shows a robot moving under what appears to be direct mind control, described by Neuralink and its participants as operating machinery "all via telepathy." The likely mechanism is a Neuralink N1 implant decoding motor-intent signals from the user's motor cortex and translating them into robot movement commands in real time; Neuralink previously demonstrated this approach with robotic arm control through its "Convoy Project" clinical study. According to Neuralink's own reporting, at least 26 individuals had received N1 implants by mid-2026, with participants averaging 50 hours of independent BCI use per week for tasks ranging from gaming to professional work to robotic arm control. The N1 chip packs up to 3,072 electrodes into a device roughly the size of a quarter, and a next-generation surgical robot introduced in early 2026 cut electrode thread insertion time to 1.5 seconds per thread and achieved compatibility with 99% of anatomical variations worldwide. In November 2025, Elon Musk outlined a roadmap for integrating Neuralink interfaces with Tesla's Optimus, and Danish Hussain, Neuralink's Head of Surgery, said a human-to-Optimus interface would happen "very soon," aimed at people who cannot speak or move independently. The first documented case of a Neuralink patient controlling a robot came in November 2025, when Alex, a patient with a cervical spinal cord injury and the second Neuralink recipient,